Crohn's Disease cA2 Study Group. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-alpha for Crohn's disease - Targan,S.R.; Hanauer,S.B.; van Deventer,J H.S. (N Engl J Med, 1997)